NASDAQ:ELOX

Eloxx Pharmaceuticals Stock Insider Trading

etoro logo Buy ELOX
*Your capital is at risk
$0.370
+0 (+0%)
At Close: Jun 03, 2026

Eloxx Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 44.75. In total, the insiders bought 59.07M and sold 1.42M ELOX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
44.75
Buy 59.07M shares
Sell 1.42M shares
95% Buy Activity
Moderate Positive Correlation
Sell Signal Low Confidence
May 27, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 44.75.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Oct 16, 2024
Buy
Common Stock
A-Award
Aggarwal Sumit
President And CEO
CEO / President 165 000
Value: $182
Oct 16, 2024
Buy
Common Stock
A-Award
Aggarwal Sumit
President And CEO
CEO / President 165 000
Value: $182
Oct 16, 2024
Buy
Common Stock
A-Award
Rubin Steven D
Director
Director 12 000
Value: $13
Oct 16, 2024
Buy
Common Stock
A-Award
Androski Lindsay
Director
Director 12 000
Value: $13
Oct 16, 2024
Buy
Common Stock
A-Award
Walts Alan Edmund
Director
Director 12 000
Value: $13
Jan 24, 2024
Buy
Restricted Stock Units
A-Award
Walts Alan Edmund
Director
Director 7 500
Value: $0
Jan 24, 2024
Buy
Restricted Stock Units
A-Award
Rubin Steven D
Director
Director 7 500
Value: $0
Jan 24, 2024
Buy
Restricted Stock Units
A-Award
Androski Lindsay
Director
Director 7 500
Value: $0
Jan 24, 2024
Buy
Restricted Stock Units
A-Award
Aggarwal Sumit
President And CEO
CEO / President 60 000
Value: $0
Jan 24, 2024
Buy
Restricted Stock Units
A-Award
Aggarwal Sumit
President And CEO
CEO / President 60 000
Value: $0
Jan 24, 2024
Buy
Restricted Stock Units
A-Award
Androski Lindsay
Director
Director 7 500
Value: $0
Jan 24, 2024
Buy
Restricted Stock Units
A-Award
Rubin Steven D
Director
Director 7 500
Value: $0
Jan 24, 2024
Buy
Restricted Stock Units
A-Award
Walts Alan Edmund
Director
Director 7 500
Value: $0
Jan 30, 2023
Buy
Stock Options (Right to Buy)
A-Award
Walts Alan Edmund
Director
Director 2 859
Value: $11.4K
Jan 30, 2023
Buy
Stock Options (Right to Buy)
A-Award
Rubin Steven D
Director
Director 2 859
Value: $11.4K
Jan 30, 2023
Buy
Stock Options (Right to Buy)
A-Award
Kariv Tomer
Director
Director 2 859
Value: $11.4K
Jan 30, 2023
Buy
Stock Options (Right to Buy)
A-Award
Androski Lindsay
Director
Director 2 859
Value: $11.4K
Jan 30, 2023
Buy
Stock Options (Right to Buy)
A-Award
Androski Lindsay
Director
Director 2 859
Value: $11.4K
Jan 30, 2023
Buy
Stock Options (Right to Buy)
A-Award
Kariv Tomer
Director
Director 2 859
Value: $11.4K
Jan 30, 2023
Buy
Stock Options (Right to Buy)
A-Award
Rubin Steven D
Director
Director 2 859
Value: $11.4K
Jan 30, 2023
Buy
Stock Options (Right to Buy)
A-Award
Walts Alan Edmund
Director
Director 2 859
Value: $11.4K
Jan 25, 2023
Buy
Stock Options (Right to Buy)
A-Award
Aggarwal Sumit
President And CEO
CEO / President 68 700
Value: $0
Jan 25, 2023
Buy
Stock Options (Right to Buy)
A-Award
Modur Vijay
Head Of R&d
Officer 30 000
Value: $0
Jan 25, 2023
Buy
Stock Options (Right to Buy)
A-Award
Modur Vijay
Head Of R&d
Officer 30 000
Value: $0
Jan 25, 2023
Buy
Stock Options (Right to Buy)
A-Award
Aggarwal Sumit
President And CEO
CEO / President 68 700
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ELOXX PHARMACEUTICALS INC.
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for t...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE